<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1441" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1441/" /><meta name="ncbi_pagename" content="Blepharophimosis, Ptosis, and Epicanthus Inversus - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Blepharophimosis, Ptosis, and Epicanthus Inversus - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Blepharophimosis, Ptosis, and Epicanthus Inversus" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/02/05" /><meta name="citation_author" content="Hannah Verdin" /><meta name="citation_author" content="Elfride De Baere" /><meta name="citation_pmid" content="20301614" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1441/" /><meta name="citation_keywords" content="Blepharophimosis Syndrome" /><meta name="citation_keywords" content="BPES" /><meta name="citation_keywords" content="BPES" /><meta name="citation_keywords" content="Blepharophimosis Syndrome" /><meta name="citation_keywords" content="Forkhead box protein L2" /><meta name="citation_keywords" content="FOXL2" /><meta name="citation_keywords" content="Blepharophimosis, Ptosis, and Epicanthus Inversus" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Blepharophimosis, Ptosis, and Epicanthus Inversus" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Hannah Verdin" /><meta name="DC.Contributor" content="Elfride De Baere" /><meta name="DC.Date" content="2015/02/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1441/" /><meta name="description" content="Blephariphimosis, ptosis, and epicanthus inversus syndrome (BPES) is a complex eyelid malformation invariably characterized by four major features: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and premature ovarian insufficiency (POI); BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include lacrimal duct anomalies, amblyopia, strabismus, and refractive errors. Minor features include a broad nasal bridge, low-set ears, and a short philtrum. Individuals with BPES and an intragenic FOXL2 pathogenic variant are expected to have normal intelligence, in contrast to affected individuals with cytogenetic rearrangements that involve FOXL2 and additional genes." /><meta name="og:title" content="Blepharophimosis, Ptosis, and Epicanthus Inversus" /><meta name="og:type" content="book" /><meta name="og:description" content="Blephariphimosis, ptosis, and epicanthus inversus syndrome (BPES) is a complex eyelid malformation invariably characterized by four major features: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and premature ovarian insufficiency (POI); BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include lacrimal duct anomalies, amblyopia, strabismus, and refractive errors. Minor features include a broad nasal bridge, low-set ears, and a short philtrum. Individuals with BPES and an intragenic FOXL2 pathogenic variant are expected to have normal intelligence, in contrast to affected individuals with cytogenetic rearrangements that involve FOXL2 and additional genes." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1441/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/bpes/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1441/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A32F8E04083F10000000006660255.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1441_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1441_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bhd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bloom/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1441_"><span class="title" itemprop="name">Blepharophimosis, Ptosis, and Epicanthus Inversus</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Blepharophimosis Syndrome, BPES</div><p class="contrib-group"><span itemprop="author">Hannah Verdin</span>, MSc, PhD and <span itemprop="author">Elfride De Baere</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1441_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1441_ai__"><div class="contrib half_rhythm"><span itemprop="author">Hannah Verdin</span>, MSc, PhD<div class="affiliation small">Center for Medical Genetics<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@nidrev.hannah" class="oemail">eb.tnegu@nidrev.hannah</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Elfride De Baere</span>, MD, PhD<div class="affiliation small">Center for Medical Genetics<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@ereabed.edirfle" class="oemail">eb.tnegu@ereabed.edirfle</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 8, 2004</span>; Last Update: <span itemprop="dateModified">February 5, 2015</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="bpes.Summary" itemprop="description"><h2 id="_bpes_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>B</i>lephariphimosis, <i>p</i>tosis, and <i>e</i>picanthus inversus <i>s</i>yndrome (BPES) is a complex eyelid malformation invariably characterized by four major features: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I includes the four major features and premature ovarian insufficiency (POI); BPES type II includes only the four major features. Other ophthalmic manifestations that can be associated with BPES include lacrimal duct anomalies, amblyopia, strabismus, and refractive errors. Minor features include a broad nasal bridge, low-set ears, and a short philtrum. Individuals with BPES and an intragenic <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are expected to have normal intelligence, in contrast to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> rearrangements that involve <i>FOXL2</i> and additional genes.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of BPES is primarily based on clinical findings. Occasionally individuals with BPES have <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> rearrangements, such as interstitial deletions and translocations involving 3q23. <i>FOXL2</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> currently known to be associated with BPES.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Timing of eyelid surgery involves balancing the benefits of early surgery to prevent deprivation amblyopia versus late surgery to allow for more reliable ptosis measurements. Surgery traditionally involves a medial canthoplasty for correction of the blepharophimosis, epicanthus inversus, and telecanthus at age three to five years, typically followed a year later by ptosis correction; recently, a one-stage surgical procedure has been described. Premature ovarian failure is treated with hormone replacement therapy; fertility is addressed with reproductive technologies such as embryo donation and egg donation.</p><p><i>Surveillance:</i> Ophthalmic follow up depends on age, procedures performed in the past, and results of visual acuity testing. Endocrinologic and gynecologic follow up are advised for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>BPES is usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance has been reported in one <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family. For autosomal dominant inheritance: Each child of an individual with BPES has a 50% chance of inheriting the <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family has been identified; however, requests for prenatal testing for conditions such as BPES are not common.</p></div></div><div id="bpes.Diagnosis"><h2 id="_bpes_Diagnosis_">Diagnosis</h2><div id="bpes.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of blepharophimosis syndrome (BPES) is based primarily on the following four clinical findings, which are present at birth [<a class="bk_pop" href="#bpes.REF.oley.1995">Oley &#x00026; Baraitser 1995</a>]:</p><ul><li class="half_rhythm"><div><b>Blepharophimosis.</b> Narrowing of the horizontal aperture of the eyelids. In normal adults, the horizontal palpebral fissure measures 25-30 mm; in individuals with BPES, it generally measures 20-22 mm.</div></li><li class="half_rhythm"><div><b>Ptosis.</b> Drooping of the upper eyelid causing a narrowing of the vertical palpebral fissure. In individuals with BPES, ptosis is secondary to dysplasia of the <i>musculus levator palpebrae superioris</i>. To compensate for the ptosis, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals:</div><ul><li class="half_rhythm"><div>Use the <i>musculus frontalis</i>, wrinkling the forehead to draw the eyebrows upward, which results in a characteristic facial appearance</div></li><li class="half_rhythm"><div>Tilt their head backward into a chin-up position</div></li></ul></li><li class="half_rhythm"><div><b>Epicanthus inversus.</b> A skin fold arising from the lower eyelid and running inwards and upwards.</div></li><li class="half_rhythm"><div><b>Telecanthus.</b> Lateral displacement of the inner canthi with normal interpupillary distance.</div></li></ul><p>Note: A study of ten individuals with molecularly confirmed BPES showed that all had lateral displacement of the inferior punctum (i.e., in the lower eyelid) resulting from a temporal displacement of the entire lower eyelid. This proved to be an important anatomical hallmark in the diagnosis of BPES [<a class="bk_pop" href="#bpes.REF.decock.2011a.368">Decock et al 2011a</a>].</p><p>Two types of blepharophimosis syndrome have been described [<a class="bk_pop" href="#bpes.REF.zlotogora.1983.1020">Zlotogora et al 1983</a>]:</p><ul><li class="half_rhythm"><div><b>BPES type I</b> includes the four major features and female infertility caused by premature ovarian insufficiency (POI).</div></li><li class="half_rhythm"><div><b>BPES type II</b> includes only the four major features.</div></li></ul></div><div id="bpes.Testing"><h3>Testing</h3><p>Females with premature ovarian insufficiency (POI) have:</p><ul><li class="half_rhythm"><div>Endocrinologic findings of hypergonadotropic hypogonadism:</div><ul><li class="half_rhythm"><div>Elevated serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH)</div></li><li class="half_rhythm"><div>Decreased serum concentrations of estradiol and progesterone</div></li></ul></li><li class="half_rhythm"><div>A small hypoplastic uterus and streak ovaries on pelvic ultrasound examination</div></li></ul><p><b>Cytogenetic testing.</b> Cytogenetic rearrangements involving 3q23 (i.e., unbalanced translocations and interstitial deletions) causing BPES have been reported [<a class="bk_pop" href="#bpes.REF.fukushima.1991.485">Fukushima et al 1991</a>, <a class="bk_pop" href="#bpes.REF.jewett.1993.1147">Jewett et al 1993</a>, <a class="bk_pop" href="#bpes.REF.boccone.1994.258">Boccone et al 1994</a>, <a class="bk_pop" href="#bpes.REF.lawson.1995.963">Lawson et al 1995</a>, <a class="bk_pop" href="#bpes.REF.de_baere.1999.70">De Baere et al 1999</a>, <a class="bk_pop" href="#bpes.REF.praphanphoj.2000.67">Praphanphoj et al 2000</a>, <a class="bk_pop" href="#bpes.REF.de_ru.2005.81">de Ru et al 2005</a>, <a class="bk_pop" href="#bpes.REF.alao.2012.630">Alao et al 2012</a>, <a class="bk_pop" href="#bpes.REF.gonz_lezgonz_lez.2012.107">Gonz&#x000e1;lez-Gonz&#x000e1;lez et al 2012</a> and references therein, <a class="bk_pop" href="#bpes.REF.schladebartusiak.2012.2322">Schlade-Bartusiak et al 2012</a>]. Such <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> rearrangements are estimated to occur in a very small fraction of individuals with BPES [<a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a>].</p><div id="bpes.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>FOXL2</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> currently known to be associated with BPES (<a class="figpopup" href="/books/NBK1441/table/bpes.T.summary_of_molecular_genetic_test/?report=objectonly" target="object" rid-figpopup="figbpesTsummaryofmoleculargenetictest" rid-ob="figobbpesTsummaryofmoleculargenetictest">Table 1</a>).</p><div id="bpes.T.summary_of_molecular_genetic_test" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Blepharophimosis, Ptosis, and Epicanthus Inversus</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1441/table/bpes.T.summary_of_molecular_genetic_test/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bpes.T.summary_of_molecular_genetic_test_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXL2</i></td><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">72%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%-15%&#x000a0;<sup>6,&#x000a0;7</sup></td></tr><tr><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regulatory regions extragenic to <i>FOXL2</i></td><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis of regions upstream of <i>FOXL2</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_bpes.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%&#x000a0;<sup>8,&#x000a0;9</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="bpes.TF.1.1"><p class="no_margin">See <a href="/books/NBK1441/#bpes.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#bpes.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="bpes.TF.1.2"><p class="no_margin">The detection rate using <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and MLPA is around 82% in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> as well as in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) [<a class="bk_pop" href="#bpes.REF.de_baere.2003.478">De Baere et al 2003</a>, <a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>, <a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a>].</p></div></dd><dt>3. </dt><dd><div id="bpes.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="bpes.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#bpes.REF.de_baere.2003.478">De Baere et al [2003]</a>, <a class="bk_pop" href="#bpes.REF.beysen.2008a.e205">Beysen et al [2008a]</a>, <a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al [2009]</a></p></div></dd><dt>5. </dt><dd><div id="bpes.TF.1.5"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>6. </dt><dd><div id="bpes.TF.1.6"><p class="no_margin">Multiplex ligation-dependent probe amplification (MPLA) detected partial- or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions in approximately 10% of individuals with typical BPES [<a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>, <a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a>].</p></div></dd><dt>7. </dt><dd><div id="bpes.TF.1.7"><p class="no_margin">Cytogenetic rearrangements involving 3q23 (i.e., unbalanced translocations and interstitial deletions) that cause BPES are often accompanied by additional findings, such as microcephaly, intellectual disability, and growth delay [<a class="bk_pop" href="#bpes.REF.fukushima.1991.485">Fukushima et al 1991</a>, <a class="bk_pop" href="#bpes.REF.jewett.1993.1147">Jewett et al 1993</a>, <a class="bk_pop" href="#bpes.REF.boccone.1994.258">Boccone et al 1994</a>, <a class="bk_pop" href="#bpes.REF.lawson.1995.963">Lawson et al 1995</a>, <a class="bk_pop" href="#bpes.REF.de_baere.1999.70">De Baere et al 1999</a>, <a class="bk_pop" href="#bpes.REF.praphanphoj.2000.67">Praphanphoj et al 2000</a>, <a class="bk_pop" href="#bpes.REF.de_ru.2005.81">de Ru et al 2005</a> and references therein, <a class="bk_pop" href="#bpes.REF.alao.2012.630">Alao et al 2012</a>, <a class="bk_pop" href="#bpes.REF.gonz_lezgonz_lez.2012.107">Gonz&#x000e1;lez-Gonz&#x000e1;lez et al 2012</a>, <a class="bk_pop" href="#bpes.REF.schladebartusiak.2012.2322">Schlade-Bartusiak et al 2012</a>]. Note: Balanced translocations involving 3q23 lead to classic BPES type I or II without additional findings.</p></div></dd><dt>8. </dt><dd><div id="bpes.TF.1.8"><p class="no_margin">MLPA and other methods for <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> (see footnote 6) may detect partial-, whole-, or contiguous-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions or upstream regulatory deletions, depending on the experimental design [<a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a>, <a class="bk_pop" href="#bpes.REF.dhaene.2009.e1000522">D'haene et al 2009</a>].</p></div></dd><dt>9. </dt><dd><div id="bpes.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al [2005]</a>, <a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al [2009]</a>, <a class="bk_pop" href="#bpes.REF.dhaene.2009.e1000522">D'haene et al [2009]</a>, <a class="bk_pop" href="#bpes.REF.verdin.2013.e1003358">Verdin et al [2013]</a></p></div></dd></dl></div></div></div></div></div><div id="bpes.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Molecular genetic testing of <i>FOXL2,</i> including <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a></div></li><li class="half_rhythm"><div>If no <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> rearrangement of <i>FOXL2</i> and neighboring region(s) can be identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> analysis may be considered depending on the family history and the individual&#x02019;s <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (e.g., <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> to screen for copy number variants in targeted regulatory regions 5' to <i>FOXL2</i> and karyotyping to screen for chromosomal structural rearrangements such as balanced translocations or inversions).</div></li><li class="half_rhythm"><div>In persons with BPES-like phenotypes without a <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> rearrangement of <i>FOXL2</i> and neighboring region(s), whole-genome <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> to screen for copy number variants [<a class="bk_pop" href="#bpes.REF.gijsbers.2008.489">Gijsbers et al 2008</a>] is recommended to identify the underlying genetic cause of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (see <a href="#bpes.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>).</div></li></ul></div></div><div id="bpes.Clinical_Characteristics"><h2 id="_bpes_Clinical_Characteristics_">Clinical Characteristics</h2><div id="bpes.Clinical_Description"><h3>Clinical Description</h3><p>Blepharophimosis syndromes (BPES) type I and type II are a complex eyelid malformation characterized by four major features, all present at birth: blepharophimosis, ptosis, epicanthus inversus, and telecanthus. BPES type I also includes female infertility caused by premature ovarian insufficiency (POI).</p><p>Other features frequently observed in both BPES type I and type II are a broad nasal bridge, low-set ears, and a short philtrum.</p><p>Associated ophthalmic manifestations include dysplastic eyelids (lack of eyelid folds and thin skin); S-shaped border of the upper eyelid and abnormal downward concavity of the lower eyelid with lateral ectropion; and nasolacrimal drainage problems caused by lateral displacement, duplication, or stenosis of the lacrimal puncta.</p><p>A retrospective study in 204 individuals with BPES showed manifest strabismus in 20%, a significant refractive error in 34%, and bilateral or unilateral amblyopia in 21% and 20%, respectively [<a class="bk_pop" href="#bpes.REF.dawson.2003.173">Dawson et al 2003</a>]. The incidences of strabismus, refractive errors (anisometropic hypermetropia and myopia), and amblyopia are higher in individuals with BPES than in the general population [<a class="bk_pop" href="#bpes.REF.beckingsale.2003.138">Beckingsale et al 2003</a>, <a class="bk_pop" href="#bpes.REF.dawson.2003.173">Dawson et al 2003</a>, <a class="bk_pop" href="#bpes.REF.choi.2006.285">Choi et al 2006</a>].</p><p>Secondary sexual characteristics are usually normal in both BPES type I and type II.</p><p>In BPES type I, menarche is usually normal, followed by oligomenorrhea and secondary amenorrhea.</p><p>Individuals with BPES who have an intragenic <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (in contrast to individuals with a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> that includes <i>FOXL2</i>) are expected to have normal intelligence.</p></div><div id="bpes.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Pathogenic variants predicted to result in proteins truncated before the polyalanine tract preferentially lead to POI (BPES type I). Note: The need for careful interpretation of <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> is illustrated by the co-occurrence of BPES type I and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> POI in a three-generation family.</p><p>Polyalanine expansions preferentially lead to BPES type II. The first case with a positive correlation between the size of the polyalanine expansion, its dosage, and the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the BPES <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was reported by <a class="bk_pop" href="#bpes.REF.nallathambi.2007.107">Nallathambi et al [2007]</a>.</p><p>Click <a href="/books/NBK1441/bin/bpes-phenotypic_spectrum.pdf">here</a> (pdf) for additional findings observed with some <i>FOXL2</i> pathogenic variants.</p></div><div id="bpes.Penetrance"><h3>Penetrance</h3><p>To date, almost all individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have the BPES <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; thus, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is nearly complete for the eyelid phenotype.</p><p>The exception is a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Indian family in which heterozygotes for a short polyalanine expansion of 19 alanines are unaffected, but homozygotes have typical BPES (with documented POI in one female) [<a class="bk_pop" href="#bpes.REF.nallathambi.2007.107">Nallathambi et al 2007</a>] (see <a href="#bpes.Molecular_Genetics">Molecular Genetics</a>).</p></div><div id="bpes.Prevalence"><h3>Prevalence</h3><p>The prevalence of BPES is unknown.</p><p>No differences in prevalence based on sex, race, or ethnicity have been reported.</p></div></div><div id="bpes.Genetically_Related_Allelic_Disorde"><h2 id="_bpes_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><b>Nonsyndromic premature ovarian insufficiency</b>
<b>(POI).</b> Considering that POI is part of the phenotypic spectrum of <i>FOXL2</i> pathogenic variants, <i>FOXL2</i> was assumed to be a possible candidate <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for nonsyndromic POI [<a class="bk_pop" href="#bpes.REF.crisponi.2001.159">Crisponi et al 2001</a>, <a class="bk_pop" href="#bpes.REF.prueitt.2001.132">Prueitt &#x00026; Zinn 2001</a>]. Novel <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant <a class="figpopup" href="/books/NBK1441/table/bpes.T.selected_foxl2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figbpesTselectedfoxl2pathogenicvariant" rid-ob="figobbpesTselectedfoxl2pathogenicvariant">p.Gly187Asp</a> was found in a woman with POI in the absence of BPES [<a class="bk_pop" href="#bpes.REF.laissue.2009.455">Laissue et al 2009</a>]. The subcellular localization of the mutant protein was normal but the transactivation capacity of the mutant protein on two ovary-specific reporter promoters proved to be lower than that of normal FOXL2 protein. In addition, the mutant protein was found to strongly activate an in vitro reporter construct driven by the <i>OSR2</i> promoter, a gene assumed to be a craniofacial target of FOXL2 protein.</p><p>Other studies found rare or no <i>FOXL2</i> sequence variants in phenotypically normal women with POI [<a class="bk_pop" href="#bpes.REF.de_baere.2001.1591">De Baere et al 2001</a>, <a class="bk_pop" href="#bpes.REF.de_baere.2002.e43">De Baere et al 2002</a>, <a class="bk_pop" href="#bpes.REF.harris.2002.729">Harris et al 2002</a>, <a class="bk_pop" href="#bpes.REF.bodega.2004.555">Bodega et al 2004</a>, <a class="bk_pop" href="#bpes.REF.gersak.2004.2767">Gersak et al 2004</a>, <a class="bk_pop" href="#bpes.REF.laissue.2009.455">Laissue et al 2009</a>].</p></div><div id="bpes.Differential_Diagnosis"><h2 id="_bpes_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of BPES includes those conditions in which ptosis or blepharophimosis is a major feature (<a class="figpopup" href="/books/NBK1441/table/bpes.T.overview_of_conditions_in_which_p/?report=objectonly" target="object" rid-figpopup="figbpesToverviewofconditionsinwhichp" rid-ob="figobbpesToverviewofconditionsinwhichp">Table 2</a>) [<a class="bk_pop" href="#bpes.REF.oley.1995">Oley &#x00026; Baraitser 1995</a>]; however, in clinical practice, blepharophimosis syndrome can be relatively easily distinguished from most of these conditions.</p><div id="bpes.T.overview_of_conditions_in_which_p" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Overview of Conditions in which Ptosis and/or Blepharophimosis is a Prominent Feature</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1441/table/bpes.T.overview_of_conditions_in_which_p/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bpes.T.overview_of_conditions_in_which_p_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Syndrome</th><th id="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Characteristics</th><th id="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM</th></tr></thead><tbody><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hereditary <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> ptosis 1 (PTOS1)</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ptosis</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/178300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">178300</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hereditary <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> ptosis 2 (PTOS2)</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ptosis</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/300245" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300245</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kat6b-dis/">Ohdo blepharophimosis syndrome</a></td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Blepharophimosis, blepharoptosis</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Hypoplastic teeth</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/249620" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">249620</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3MC syndrome 1 (Michels syndrome)</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Blepharophimosis, blepharoptosis, epicanthus inversus, ophthalmic anterior segment defects (cornea)</div></li><li class="half_rhythm"><div>Cleft lip/palate</div></li><li class="half_rhythm"><div>Minor skeletal abnormalities</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/257920" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">257920</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ptosis with external ophthalmoplegia</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ptosis, ophthalmoplegia, miosis, decreased accommodation, strabismus, amblyopia</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/258400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">258400</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/noonan/">Noonan syndrome</a></td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Heart defects</div></li><li class="half_rhythm"><div>Blood clotting deficiencies</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/163950" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">163950</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Marden-Walker syndrome</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ptosis, blepharophimosis</div></li><li class="half_rhythm"><div>Growth retardation</div></li><li class="half_rhythm"><div>Neurologic defects (ID, absent primitive reflexes)</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/248700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">248700</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Schwartz-Jampel syndrome</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ptosis (intermittent), blepharophimosis, telecanthus, cataract</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Cartilage &#x00026; skeletal anomalies</div></li><li class="half_rhythm"><div>Muscle hypertrophy</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/255800" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">255800</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dubowitz syndrome</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ptosis, blepharophimosis, lateral telecanthus</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Immunologic deficiencies</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/223370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">223370</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/slo/">Smith-Lemli-Opitz syndrome</a></td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ptosis, epicanthus, cataract</div></li><li class="half_rhythm"><div>Growth retardation, ID</div></li><li class="half_rhythm"><div>Severe GU, cardiac, GI anomalies</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/270400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">270400</a></td></tr><tr><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mdel17q21_31/"><i>KANSL1</i>-related intellectual disability syndrome</a> (17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/microdeletion-syndrome/">microdeletion syndrome</a>)&#x000a0;<sup>2</sup></td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>DD w/mild-to-moderate ID</div></li><li class="half_rhythm"><div>Characteristic facies: long face, high forehead, ptosis, blepharophimosis, large low-set ears, bulbous nasal tip, pear-shaped nose</div></li><li class="half_rhythm"><div>Nasal speech</div></li><li class="half_rhythm"><div>Cardiac septal defects, seizures, cryptorchidism</div></li><li class="half_rhythm"><div>Friendly disposition</div></li></ul>
</td><td headers="hd_h_bpes.T.overview_of_conditions_in_which_p_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://omim.org/entry/610443" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610443</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#bpes.REF.oley.1995">Oley &#x00026; Baraitser [1995]</a>, <a href="http://omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; GI = gastrointestinal; GU = genitourinary; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="bpes.TF.2.1"><p class="no_margin">Presumed <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>2. </dt><dd><div id="bpes.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#bpes.REF.gijsbers.2008.489">Gijsbers et al [2008]</a></p></div></dd></dl></div></div></div></div><div id="bpes.Management"><h2 id="_bpes_Management_">Management</h2><div id="bpes.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with blepharophimosis syndrome (BPES), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Examination by a (pediatric) ophthalmologist for visual acuity, refractive error, extraocular movement, strabismus, size of palpebral apertures, and eyelid elevation. Those with amblyopia or strabismus should be referred to a pediatric ophthalmologist for management [<a class="bk_pop" href="#bpes.REF.beckingsale.2003.138">Beckingsale et al 2003</a>].</div></li><li class="half_rhythm"><div>Genetic evaluation and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> by a clinical geneticist to discuss <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> and assess risk for premature ovarian insufficiency (POI). In girls with BPES, the family history can indicate the type of BPES in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females (with type I inferred by the association with subfertility or infertility). In uninformative families or <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., single occurrence in a family), <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> may be helpful in some cases in assessing the risk for POI.</div></li><li class="half_rhythm"><div>Referral of females with BPES to a pediatric or adult endocrinologist during late puberty or early adulthood to assess onset and course of POI</div></li></ul></div><div id="bpes.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management requires the input of specialists including a clinical geneticist, pediatric ophthalmologist, oculoplastic surgeon, (pediatric or adult) endocrinologist, reproductive endocrinologist, and gynecologist.</p><p><b>Eyelid surgery.</b> Timing of eyelid surgery is controversial; it involves weighing the balance of early surgery to prevent deprivation amblyopia and late surgery to allow for more reliable ptosis measurements, the latter of which provides a better surgical outcome. Furthermore, ptosis surgery is hampered by the dysplastic structure of the eyelids [<a class="bk_pop" href="#bpes.REF.beckingsale.2003.138">Beckingsale et al 2003</a>].</p><p>The surgical management is traditionally performed in two stages and involves a medial canthoplasty for correction of the blepharophimosis, epicanthus inversus, and telecanthus at ages three to five years, followed about a year later by ptosis correction, which usually requires a brow suspension procedure.</p><p>Many surgical techniques have been described for medial canthoplasty and none of the existing methods is free from criticism. If the epicanthal folds are small, a Y-V canthoplasty is traditionally used; if the epicanthal folds are severe, a double Z-plasty is used. An alternate technique for medial canthoplasty has been described recently using the skin redraping method, which has a simple flap design, less scarring, and the effective repair of epicanthus inversus and telecanthus [<a class="bk_pop" href="#bpes.REF.sa.2012.2402">Sa et al 2012</a>].</p><p>To correct telecanthus, the medial canthal tendon is usually shortened or fused with a transnasal wire.</p><p>Ptosis correction is particularly important as it can address the disfigurement as well as functional concerns. Frontal muscle flap suspension is mostly used for severe ptosis in adults; however, it remains controversial. A major concern is that the frontal muscle development may be restrained by surgery. <a class="bk_pop" href="#bpes.REF.decock.2011b.1018">Decock et al [2011b]</a> reported that super-maximal resection and frontalis suspension is the preferred method as it leads to a good cosmetic outcome as well as to an improved muscle function.</p><p>Alternatively, a one-stage procedure in which medial canthoplasty and ptosis correction are performed simultaneously has been described [<a class="bk_pop" href="#bpes.REF.wu.2008.380">Wu et al 2008</a>]. Two recent retrospective, interventional studies including 21 patients demonstrated that one-stage correction using a standard combination of surgical techniques is safe and efficient [<a class="bk_pop" href="#bpes.REF.sebasti_.2011.820">Sebasti&#x000e1; et al 2011</a>, <a class="bk_pop" href="#bpes.REF.liu.2014.74">Liu et al 2014</a>].</p><p>Recent insights into the causes of the abnormal lower eyelid positioning allow a more targeted surgical reconstruction that produces a more natural appearance [<a class="bk_pop" href="#bpes.REF.decock.2011a.368">Decock et al 2011a</a>]. Ten individuals with molecularly proven BPES were noted to have a laterally displaced inferior punctum (i.e., in the lower eyelid) due to temporal displacement of the entire lower eyelid. Addition of a simple surgical step corrected the position of the lower eyelid and its abnormal downward concavity (the temporal ectropion), and the lateral displacement of the inferior punctum. This approach eliminates the epicanthus inversus fold without the need for double Z-plasty [<a class="bk_pop" href="#bpes.REF.decock.2011b.1018">Decock et al 2011b</a>].</p><p><b>Ovarian insufficiency.</b> Management of premature ovarian insufficiency (POI) needs to address the two following major medical issues that are applicable to primary ovarian insufficiency in general and not specific for BPES (no data specific to BPES are available):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Hormone replacement therapy (HRT).</b> The American Society for Reproductive Medicine and the International Menopause Society recommend estrogen replacement therapy for women with primary ovarian insufficiency (amenorrhea and a menopausal serum FSH concentration). Although no data from randomized trials guide the use of hormonal therapy in women with BPES and POI, a reasonable regimen would be 100 &#x003bc;g of transdermal estradiol and 10 mg of oral medroxyprogesterone acetate daily for the first 12 days of each month. Women should keep a menstrual calendar and have a pregnancy test promptly in the case of late menses [<a class="bk_pop" href="#bpes.REF.nelson.2009.606">Nelson 2009</a>].</div><div class="half_rhythm">A pelvic ultrasound examination and measurement of bone mineral density are indicated at the time of diagnosis of ovarian insufficiency. Women with primary ovarian insufficiency should be encouraged to maintain a lifestyle that optimizes bone and cardiovascular health, including engaging in regular weight-bearing exercise, maintaining an adequate intake of calcium (1200 mg daily) and vitamin D (at least 800 IU daily), eating a healthy diet to avoid obesity, and undergoing screening for cardiovascular risk factors, with treatment of any identified risk factors.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Infertility.</b> No therapies have been shown to restore ovarian function and fertility. Some couples are averse to adoption and to reproductive technologies and are content not to become parents.</div><div class="half_rhythm">For couples who decide to pursue parenthood actively, the options are adoption, foster parenthood, embryo donation, and egg donation. The rates of pregnancy with egg donation appear to be similar among older and younger women. Women with primary ovarian insufficiency who become pregnant as a result of oocyte donation may have an increased risk of delivering infants who are small for gestational age and of having pregnancy-induced hypertension and postpartum hemorrhage, but these findings are controversial [<a class="bk_pop" href="#bpes.REF.nelson.2009.606">Nelson 2009</a>].</div><div class="half_rhythm">The issue of POI is emotionally charged and should be discussed with the patient with this in mind.</div></li></ul></div><div id="bpes.Surveillance"><h3>Surveillance</h3><p>The frequency of ophthalmic follow-up should be individualized depending on age, procedures performed in the past, and results of visual acuity testing.</p><p>Endocrinologic and gynecologic follow up are advised in females in whom the BPES type is unknown or in whom BPES type I is suspected based on a positive family history or <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Frequency of endocrinologic follow-up to monitor ovarian status is individualized and can involve pelvic ultrasound examination, measurement of serum FSH concentrations, and assessment of menstrual pattern (ages of menarche and onset of oligomenorrhea and secondary amenorrhea).</p></div><div id="bpes.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#bpes.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="bpes.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Ovarian transplantation has been performed in rare instances in which the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> woman has an identical twin sister with normal ovarian function [<a class="bk_pop" href="#bpes.REF.nelson.2009.606">Nelson 2009</a>].</p><p>Note: (1) Cryopreservation has not yet been reported in BPES. (2) Children who are at risk for POI are most likely to benefit from cryopreservation as their ovaries contain more primordial follicles than those of adult women; it is expected that by the time these children are mature and need their ovarian tissue, the modalities for its optimal use would become available. (3) At the time that they might wish to consider an IVF procedure, adult women with BPES usually do not have sufficient appropriate primordial follicles for embryo cryopreservation.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="bpes.Genetic_Counseling"><h2 id="_bpes_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="bpes.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is almost always inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Autosomal recessive inheritance has been reported in a single <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> family [<a class="bk_pop" href="#bpes.REF.nallathambi.2007.107">Nallathambi et al 2007</a>].</p></div><div id="bpes.Risk_to_Family_Members__Autosomal_D"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> BPES have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with AD BPES may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>FOXL2</i> if the pathogenic variant has been identified in the proband and clinical examination for subtle features of BPES.</div></li></ul><p>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> [unpublished data].</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected and do not have a <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If a <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. The risk to the sibs of the proband depends on the probability of germline mosaicism in a parent of the proband and the spontaneous mutation rate of <i>FOXL2</i>.</div></li><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been observed in AD BPES and demonstrated at the molecular level [<a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>]; its incidence is unknown.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with AD BPES has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="bpes.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that pathogenic variant occurred <i>de novo</i> in the proband. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. In addition, families in which (1) women with BPES have had premature ovarian failure or (2) women with BPES have an unknown risk for premature ovarian insufficiency (POI) should be informed regarding this risk so that they may consider early childbearing.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="bpes.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for BPES are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="bpes.Resources"><h2 id="_bpes_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>FACES: The National Craniofacial Association</b></div><div>PO Box 11082</div><div>Chattanooga TN 37401</div><div><b>Phone:</b> 800-332-2373 (toll-free)</div><div><b>Email:</b> faces@faces-cranio.org</div><div><a href="http://www.faces-cranio.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faces-cranio.org</a></div></li></ul></div><div id="bpes.Molecular_Genetics"><h2 id="_bpes_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="bpes.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Blepharophimosis, Ptosis, and Epicanthus Inversus: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1441/table/bpes.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bpes.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_bpes.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_bpes.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_bpes.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_bpes.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_bpes.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_bpes.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_bpes.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/668" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FOXL2</i></a></td><td headers="hd_b_bpes.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=668" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3q22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_bpes.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P58012" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Forkhead box protein L2</a></td><td headers="hd_b_bpes.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FOXL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXL2 homepage - FOXL2 @ LOVD</a></td><td headers="hd_b_bpes.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FOXL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXL2</a></td><td headers="hd_b_bpes.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FOXL2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXL2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="bpes.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="bpes.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Blepharophimosis, Ptosis, and Epicanthus Inversus (<a href="/omim/110100,605597" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1441/table/bpes.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bpes.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/110100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">110100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605597" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605597</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>FOXL2</i> is a small single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of 2.7 kb. The entire <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a> is highly conserved in several vertebrate species [<a class="bk_pop" href="#bpes.REF.cocquet.2002.916">Cocquet et al 2002</a>, <a class="bk_pop" href="#bpes.REF.cocquet.2003.206">Cocquet et al 2003</a>, <a class="bk_pop" href="#bpes.REF.udar.2003.222">Udar et al 2003</a>]. For a detailed summary of gene and protein information, see <a href="/books/NBK1441/#bpes.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> The normal alleles have 14 copies of the Ala repeat, p.Ala221[14]. See <a class="figpopup" href="/books/NBK1441/table/bpes.T.selected_foxl2_benign_variants/?report=objectonly" target="object" rid-figpopup="figbpesTselectedfoxl2benignvariants" rid-ob="figobbpesTselectedfoxl2benignvariants">Table 3</a>.</p><div id="bpes.T.selected_foxl2_benign_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>FOXL2</i> Benign Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1441/table/bpes.T.selected_foxl2_benign_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bpes.T.selected_foxl2_benign_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bpes.T.selected_foxl2_benign_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_bpes.T.selected_foxl2_benign_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bpes.T.selected_foxl2_benign_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bpes.T.selected_foxl2_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_bpes.T.selected_foxl2_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala221[14]&#x000a0;<sup>2</sup></td><td headers="hd_h_bpes.T.selected_foxl2_benign_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/239735513" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_023067<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/12751477" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_075555<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bpes.TF.3.1"><p class="no_margin">The polyalanine expansion is an imperfect <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> that may consist of each of the four codons for alanine (GCA, GCC, GCG, GCT). Nucleotide changes resulting in varying numbers of Ala repeats are described as deletions and duplications (for details see <a href="http://databases.lovd.nl/shared/genes/FOXL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LOVD database</a>).</p></div></dd><dt>2. </dt><dd><div id="bpes.TF.3.2"><p class="no_margin">Indicates that a stretch of alanines (Ala) is present, starting at amino acid position 221. Benign variants are designated as p.Ala221[14] because they have exactly 14 Ala repeat units.</p></div></dd></dl></div></div></div><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1441/table/bpes.T.selected_foxl2_pathogenic_variant/?report=objectonly" target="object" rid-figpopup="figbpesTselectedfoxl2pathogenicvariant" rid-ob="figobbpesTselectedfoxl2pathogenicvariant">Table 4</a>. More than 125 <i>FOXL2</i> pathogenic variants have been described in individuals with BPES type I and type II, demonstrating that both phenotypic features (eyelid defect and POI) are caused by the pleiotropic effect of mutation of a single <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, rather than by a contiguous gene syndrome. To date, a total of 106 unique intragenic <i>FOXL2</i> pathogenic variants (i.e., different pathogenic variants that are unique to the world-wide collection of allelic variants) have been identified in 206 unrelated, ethnically diverse families with BPES [<a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a> and references therein]. Detailed information on most <i>FOXL2</i> pathogenic variants and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals or families with BPES is available in the <i>FOXL2</i> Mutation Database (see <a href="/books/NBK1441/#bpes.molgen.TA">Table A</a>). Each family has a unique <i>FOXL2</i> database identifier (FOXL2db-Id), indicated with a number and the prefix "FOXL2."</p><p>The occurrence of two mutational hot spots previously described by the author [<a class="bk_pop" href="#bpes.REF.de_baere.2001.1591">De Baere et al 2001</a>, <a class="bk_pop" href="#bpes.REF.de_baere.2003.478">De Baere et al 2003</a>] was corroborated by subsequent findings. Pathogenic variants leading to an expansion of the poly-Ala tract account for 31% (63/206) and the 17-bp <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> c.843_859dup accounts for 13% (26/206) of all intragenic <i>FOXL2</i> pathogenic variants. Another, less frequent 17-bp duplication c.855_871dup, along with c.841_857dup, c.843_865dup, c.854delC, and c.855_871del17, are all clustered, perhaps because of the hypermutability of this region. Other less frequent pathogenic variants are c.655C&#x0003e;T and c.804dupC [<a class="bk_pop" href="#bpes.REF.de_baere.2003.478">De Baere et al 2003</a>, <a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a>].</p><p>Larger <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> rearrangements, including deletions involving <i>FOXL2</i>, accounted for 10% of the molecular defects found in families with typical BPES [<a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>]. The extent of the deletions ranges from a partial- and total-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> to microdeletions encompassing <i>FOXL2</i> and neighboring genes including the Seckel syndrome-associated gene, <i>ATR</i>, located 5&#x02019; to <i>FOXL2</i> [<a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>, <a class="bk_pop" href="#bpes.REF.dhaene.2010.e1332">D'haene et al 2010</a>]. Cytogenetically detectable deletions include a 7.7-Mb deletion encompassing <i>FOXL2</i> and <i>ATR</i> in an individual with BPES with microcephaly and developmental delay [<a class="bk_pop" href="#bpes.REF.de_ru.2005.81">de Ru et al 2005</a>], a deletion of unknown extent in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case involving an individual with BPES and normal psychomotor development [<a class="bk_pop" href="#bpes.REF.or.2006.49">Or et al 2006</a>], and others reviewed in <a class="bk_pop" href="#bpes.REF.de_ru.2005.81">de Ru et al [2005]</a> and references therein.</p><p>Rearrangements outside the <i>FOXL2</i> transcription unit are estimated to account for 5% of all molecular defects found in BPES [<a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>] and implicate an effect of long-range <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a>-regulatory elements in regulating FOXL2 expression.</p><ul><li class="half_rhythm"><div>The occurrence of three <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> breakpoints located upstream of <i>FOXL2</i> [<a class="bk_pop" href="#bpes.REF.de_baere.2000.296">De Baere et al 2000</a>, <a class="bk_pop" href="#bpes.REF.praphanphoj.2000.67">Praphanphoj et al 2000</a>, <a class="bk_pop" href="#bpes.REF.crisponi.2004.757">Crisponi et al 2004</a>] illustrated that a position effect may also be implicated in the causation of BPES.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al [2005]</a> reported on five <i>FOXL2</i>-extragenic deletions in individuals with typical features of BPES.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#bpes.REF.dhaene.2009.e1000522">D'haene et al [2009]</a> reported four novel regulatory deletions of which one was as small as 7.4 kb and, thus, defines the crucial <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a>-regulatory region containing the long non-coding RNA <i>PISRT1</i>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#bpes.REF.gonz_lezgonz_lez.2012.107">Gonz&#x000e1;lez-Gonz&#x000e1;lez et al [2012]</a> reported a girl with BPES with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> apparently balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> between chromosomes 3 and 15: t(3;15)(q23;q25) and a 62.3-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at the 3q23 translocation breakpoint encompassing <i>PISRT1</i>.</div></li></ul><p>In a four-generation Chinese family with BPES type II showing linkage to the <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, an <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> in the 3' UTR of <i>FOXL2</i> segregated with the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. This variant was shown to be located in an AU-rich repeat; however, the functional significance of this 3' UTR insertion on FOXL2 transcript stability and translation remains to be proven [<a class="bk_pop" href="#bpes.REF.qian.2004.19">Qian et al 2004</a>].</p><p>In addition, one 5&#x02019; UTR and two 3&#x02019; UTR variants were identified in Chinese families with BPES [<a class="bk_pop" href="#bpes.REF.li.2009.257">Li et al 2009</a>]; however, the functional significance of these UTR variants on FOXL2 transcript stability and translation are not yet demonstrated.</p><div id="bpes.T.selected_foxl2_pathogenic_variant" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>FOXL2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1441/table/bpes.T.selected_foxl2_pathogenic_variant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__bpes.T.selected_foxl2_pathogenic_variant_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.560G&#x0003e;A</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly187Asp</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/239735513" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_023067<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/12751477" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_075555<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.650C&#x0003e;T</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser217Phe</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.655C&#x0003e;T</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln219Ter</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala221(15_24)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.804dupC</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly269ArgfsTer265</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.841_857dup</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro287ArgfsTer75</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.843_859dup</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro287ArgfsTer75</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.843_865dup</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His289ArgfsTer75</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.854delC</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro285ArgfsTer71</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.855_871dup</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His291ArgfsTer71</td></tr><tr><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.855_871del17</td><td headers="hd_h_bpes.T.selected_foxl2_pathogenic_variant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro287AlafsTer241</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. GeneReviews staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: GeneReviews follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="bpes.TF.4.1"><p class="no_margin">Note: The polyalanine expansion does not result from a simple <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a>, but often consists of each of the four codons for alanine (GCA, GCC, GCG, GCT). Nucleotide changes resulting in varying numbers of Ala repeats are described as deletions and duplications (for details see <a href="http://databases.lovd.nl/shared/genes/FOXL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LOVD database</a>).</p></div></dd><dt>2. </dt><dd><div id="bpes.TF.4.2"><p class="no_margin">Indicates that a stretch of alanines (Ala) is present, starting at amino acid position 221, which is found with a variable length from 14 to 24; the underscore is used to indicate the range (from residue to residue). Benign alleles are designated as p.Ala221[14] because they have exactly 14 Ala repeat units (<a class="figpopup" href="/books/NBK1441/table/bpes.T.selected_foxl2_benign_variants/?report=objectonly" target="object" rid-figpopup="figbpesTselectedfoxl2benignvariants" rid-ob="figobbpesTselectedfoxl2benignvariants">Table 3</a>); Pathogenic alleles, designated as p.Ala221(15_24), can have 15 to 24 Ala repeat units (for details see <a href="http://databases.lovd.nl/shared/genes/FOXL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LOVD database</a>).</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The FOXL2 protein of 376 amino acids belongs to the large family of winged-helix/forkhead transcription factors. Forkhead proteins are present in all eukaryotes and have important functions in the establishment of the body axis and the development of tissues from all three layers in animals. Apart from the following two domains no similarities to other known proteins or domains have been identified [<a class="bk_pop" href="#bpes.REF.crisponi.2001.159">Crisponi et al 2001</a>].</p><ul><li class="half_rhythm"><div>FOXL2 also contains a characteristic DNA-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of 110 amino acids that was originally identified in <i>Drosophila melanogaster</i> fork head mutant; the domain was nearly perfectly conserved between fork head and the mammalian HNF-3 transcription factors.</div></li><li class="half_rhythm"><div>FOXL2 contains a polyalanine tract of 14 residues, the role of which has not yet been elucidated. Expansions from 14 to 24 alanine residues in this region represent about 30% of all intragenic <i>FOXL2</i> pathogenic variants and lead mainly to BPES type II [<a class="bk_pop" href="#bpes.REF.de_baere.2003.478">De Baere et al 2003</a>].</div></li></ul><p>Click <a href="/books/NBK1441/bin/bpes-normal_gene_product.pdf">here</a> (pdf) for detailed information on forkhead <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a>, evolution, expression, subcellular localization, protein interactions.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> In general, <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of FOXL2 appears to be the cause of BPES as 82% of pathogenic variants are either intragenic variants or partial/total deletions of <i>FOXL2</i> or microdeletions and submicroscopic deletions encompassing <i>FOXL2</i> and neighboring genes [<a class="bk_pop" href="#bpes.REF.de_baere.2001.1591">De Baere et al 2001</a>, <a class="bk_pop" href="#bpes.REF.de_baere.2003.478">De Baere et al 2003</a>, <a class="bk_pop" href="#bpes.REF.beysen.2005.205">Beysen et al 2005</a>, <a class="bk_pop" href="#bpes.REF.beysen.2009.158">Beysen et al 2009</a>, <a class="bk_pop" href="#bpes.REF.dhaene.2010.e1332">D'haene et al 2010</a>].</p><p>In recent years, some insights into the phenotypic effects of <i>FOXL2</i> pathogenic variants were gained by in vitro studies of several types of natural and artificial <i>FOXL2</i> variants. It was shown that the most recurrent polyalanine expansion led to intranuclear aggregation and mislocalization of the protein as a result of extensive cytoplasmic aggregation, whereas the normal FOXL2 protein exclusively localizes in the nucleus in a diffuse manner [<a class="bk_pop" href="#bpes.REF.caburet.2004.932">Caburet et al 2004</a>]. Moreover, a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect was demonstrated. Although polyalanine expansions cause an eyelid <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> indistinguishable from that caused by other intragenic variants, a mild ovarian phenotype is observed only in a fraction of heterozygotes. This may be attributed to a difference in functional thresholds or in tissue-specific aggregation of the mutated protein in eyelid mesenchyme and follicular cells, due to tissue-specific co-aggregation partners [<a class="bk_pop" href="#bpes.REF.caburet.2004.932">Caburet et al 2004</a>]. In turn, the small polyalanine expansion (19 alanines) only leads to cytoplasmic staining in a minority of transfected cells and to no detectable aggregation [<a class="bk_pop" href="#bpes.REF.nallathambi.2007.107">Nallathambi et al 2007</a>]. Subsequently it was shown that polyalanine expansions lead to protein mislocalization, aggregation and altered intranuclear mobility in a length-dependent manner. Luciferase assays and real time RT-<a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> of several target genes showed that various polyalanine expansions induce differential downregulation depending on the target promoters analyzed [<a class="bk_pop" href="#bpes.REF.moumn_.2008.1010">Moumn&#x000e9; et al 2008</a>].</p><p>Moreover, it was shown that the steroidogenic acute regulatory <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>STAR</i> (<i>StAR</i>), whose protein is a marker of granulosa cell differentiation, is a direct target gene of FOXL2, acting as a repressor of <i>StAR</i> [<a class="bk_pop" href="#bpes.REF.pisarska.2004.3424">Pisarska et al 2004</a>]. Two disease-associated truncating <i>FOXL2</i> variants (truncation of 93 and 218 amino acids) did not result in complete loss of repressor activity. In addition, these FOXL2 truncated proteins were shown to exhibit a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect. It was concluded that the entire alanine/proline-rich carboxyl terminus is important for the repressor activity of FOXL2 and that truncating variants may preferentially lead to BPES and ovarian dysfunction by accelerated differentiation of granulosa cells and secondary depletion of the primordial follicle pool [<a class="bk_pop" href="#bpes.REF.pisarska.2004.3424">Pisarska et al 2004</a>]. The identification of a considerable number of ovarian <i>FOXL2</i> targets [<a class="bk_pop" href="#bpes.REF.batista.2007.3330">Batista et al 2007</a>] may be essential to reveal more insight into phenotypic effects of <i>FOXL2</i> pathogenic variants in the (adult) ovary.</p><p>Several artificial (i.e., not naturally occurring or reported pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals but constructed in vitro) <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have been shown to lead to the production of N-terminal truncated proteins by reinitiation of translation downstream of the premature stop codon. They display strong nuclear aggregation, and partial mislocalization to the cytoplasm. In addition, it was shown that these truncated proteins retain a fraction of the <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a> protein, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect. Luciferase assays with natural nonsense variants demonstrated the importance of the entire alanine/proline-rich carboxyl terminus of FOXL2 for transcriptional repression of the <i>STAR</i> (<i>StAR</i>) promoter. It was also demonstrated that these pathogenic variants produce a protein with a weak dominant-negative effect [<a class="bk_pop" href="#bpes.REF.moumn_.2005.3557">Moumn&#x000e9; et al 2005</a>].</p><p>The present authors subsequently studied the molecular consequences of 17 naturally occurring <i>FOXL2</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. Most mapped to the conserved DNA-binding forkhead <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. The subcellular localization and aggregation pattern of the mutated FOXL2 proteins was variable and ranged from a diffuse nuclear distribution (resembling <a class="def" href="/books/n/gene/glossary/def-item/wild-type/">wild-type</a>) to extensive nuclear aggregation often in combination with cytoplasmic mislocalization and aggregation. The authors also studied the transactivation capacity of the mutated proteins in FOXL2-expressing cells. Several led to a loss of function, while others are suspected to induce a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect. Interestingly, one variant located outside the forkhead domain (p.Ser217Phe) appeared to be a hypermorphic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, i.e. causing an increase in normal <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> function, leading to a mild BPES <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#bpes.REF.beysen.2008b.2030">Beysen et al 2008b</a>].</p><p>Click <a href="/books/NBK1441/bin/bpes-abnormal_gene_product.pdf">here</a> (pdf) for detailed information on polled intersex syndrome (PIS) in goat and mouse models, structure, evolution, and expression.</p></div><div id="bpes.References"><h2 id="_bpes_References_">References</h2><div id="bpes.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.alao.2012.630">Alao MJ, Lal&#x000e8;y&#x000e8; A, Lalya F, Hans Ch, Abramovicz M, Morice-Picard F, Arveiler B, Lacombe D, Rooryck C. Blepharophimosis, ptosis, epicanthus inversus syndrome with translocation and deletion at chromosome 3q23 in a black African female. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:630–4.</span> [<a href="/pubmed/22906557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22906557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.batista.2007.3330">Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA. Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:3330–5.</span> [<a href="/pmc/articles/PMC1805535/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1805535</span></a>] [<a href="/pubmed/17360647" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17360647</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.beckingsale.2003.138">Beckingsale PS, Sullivan TJ, Wong VA, Oley C. Blepharophimosis: a recommendation for early surgery in patients with severe ptosis. <span><span class="ref-journal">Clin Experiment Ophthalmol. </span>2003;<span class="ref-vol">31</span>:138–42.</span> [<a href="/pubmed/12648048" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12648048</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.beysen.2008a.e205">Beysen D, De Jaegere S, Mowat D, Laframboise R, Gillessen-Kaesbach G, Fellous M, Veitia RA, Boucard P, Touraine P, Leroy BP, De Cock C, Delbeke P, Leppig K, Ensenauer R, Ebinger F, Barel D, Plomp A, Kimonis V, Hendriks Y, Clayton-Smith J, Grix AW, Van Regemorter N, Hennekam R, Meire F, Oyen N, Wilson LC, De Paepe A, De Baere E. Mutation in Brief: Identification of 34 novel and 56 known <em>FOXL2</em> mutations in patients with blepharophimosis syndrome. <span><span class="ref-journal">Hum Mutat. </span>2008a;<span class="ref-vol">29</span>:E205–19.</span> [<a href="/pubmed/18642388" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18642388</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.beysen.2009.158">Beysen D, De Paepe A, De Baere E. Mutation update: <em>FOXL2</em> mutations and genomic rearrangements in BPES. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:158–69.</span> [<a href="/pubmed/18726931" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18726931</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.beysen.2008b.2030">Beysen D, Moumn&#x000e9; L, Veitia R, Peters H, Leroy BP, De Paepe A, De Baere E. Missense mutations in the forkhead domain of the transcription factor <em>FOXL2</em> lead to nuclear and cytoplasmic protein aggregation. <span><span class="ref-journal">Hum Mol Genet. </span>2008b;<span class="ref-vol">17</span>:2030–8.</span> [<a href="/pubmed/18372316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18372316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.beysen.2005.205">Beysen D, Raes J, Leroy BP, Lucassen A, Yates JR, Clayton-Smith J, Ilyina H, Brooks SS, Christin-Maitre S, Fellous M, Fryns JP, Kim JR, Lapunzina P, Lemyre E, Meire F, Messiaen LM, Oley C, Splitt M, Thomson J, Van de Peer Y, Veitia RA, De Paepe A, De Baere E. Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:205–18.</span> [<a href="/pmc/articles/PMC1224524/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1224524</span></a>] [<a href="/pubmed/15962237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15962237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.boccone.1994.258">Boccone L, Meloni A, Falchi AM, Usai V, Cao A. Blepharophimosis, ptosis, epicanthus inversus syndrome, a new case associated with de novo balanced autosomal translocation. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">51</span>:258–9.</span> [46,XY,t(3;7)(q23;q32)] [<a href="/pubmed/8074155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8074155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.bodega.2004.555">Bodega B, Porta C, Crosignani PG, Ginelli E, Marozzi A. Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. <span><span class="ref-journal">Mol Hum Reprod. </span>2004;<span class="ref-vol">10</span>:555–7.</span> [<a href="/pubmed/15181179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15181179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.caburet.2004.932">Caburet S, Demarez A, Moumne L, Fellous M, De Baere E, Veitia RA. A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:932–6.</span> [<a href="/pmc/articles/PMC1735658/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735658</span></a>] [<a href="/pubmed/15591279" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15591279</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.choi.2006.285">Choi KH, Kyung S, Oh SY. The factors influencing visual development in blepharophimosis-ptosis-epicanthus inversus syndrome. <span><span class="ref-journal">J Pediatr Ophthalmol Strabismus. </span>2006;<span class="ref-vol">43</span>:285–8.</span> [<a href="/pubmed/17022162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17022162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.cocquet.2003.206">Cocquet J, De Baere E, Gareil M, Pannetier M, Xia X, Fellous M, Veitia RA. Structure, evolution and expression of the FOXL2 transcription unit. <span><span class="ref-journal">Cytogenet Genome Res. </span>2003;<span class="ref-vol">101</span>:206–11.</span> [<a href="/pubmed/14684984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14684984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.cocquet.2002.916">Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M, Veitia RA. Evolution and expression of FOXL2. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:916–21.</span> [<a href="/pmc/articles/PMC1757225/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757225</span></a>] [<a href="/pubmed/12471206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12471206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.crisponi.2001.159">Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">27</span>:159–66.</span> [<a href="/pubmed/11175783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11175783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.crisponi.2004.757">Crisponi L, Uda M, Deiana M, Loi A, Nagaraja R, Chiappe F, Schlessinger D, Cao A, Pilia G. FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. <span><span class="ref-journal">Genomics. </span>2004;<span class="ref-vol">83</span>:757–64.</span> [<a href="/pubmed/15081106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15081106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.dawson.2003.173">Dawson EL, Hardy TG, Collin JR, Lee JP. The incidence of strabismus and refractive error in patients with blepharophimosis, ptosis and epicanthus inversus syndrome (BPES). <span><span class="ref-journal">Strabismus. </span>2003;<span class="ref-vol">11</span>:173–7.</span> [<a href="/pubmed/14710475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14710475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.de_baere.2003.478">De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP, Garza A, Jonsrud C, Koivisto PA, Krause A, Leroy BP, Meire F, Plomp A, Van Maldergem L, De Paepe A, Veitia R, Messiaen L. FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:478–87.</span> [<a href="/pmc/articles/PMC379240/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379240</span></a>] [<a href="/pubmed/12529855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12529855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.de_baere.2001.1591">De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K, Gillerot Y, Mortier G, Meire F, Van Maldergem L, Courtens W, Hjalgrim H, Huang S, Liebaers I, Van Regemorter N, Touraine P, Praphanphoj V, Verloes A, Udar N, Yellore V, Chalukya M, Yelchits S, De Paepe A, Kuttenn F, Fellous M, Veitia R, Messiaen L. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:1591–600.</span> [<a href="/pubmed/11468277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11468277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.de_baere.2000.296">De Baere E, Fukushima Y, Small K, Udar N, Van Camp G, Verhoeven K, Palotie A, De Paepe A, Messiaen L. Identification of BPESC1, a novel gene disrupted by a balanced chromosomal translocation, t(3;4)(q23;p15.2), in a patient with BPES. <span><span class="ref-journal">Genomics. </span>2000;<span class="ref-vol">68</span>:296–304.</span> [<a href="/pubmed/10995571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10995571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.de_baere.2002.e43">De Baere E, Lemercier B, Christin-Maitre S, Durval D, Messiaen L, Fellous M, Veitia R. FOXL2 mutation screening in a large panel of POF patients and XX males. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:e43.</span> [<a href="/pmc/articles/PMC1735205/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735205</span></a>] [<a href="/pubmed/12161610" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12161610</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.de_baere.1999.70">De Baere E, Van Roy N, Speleman F, Fukushima Y, De Paepe A, Messiaen L. Closing in on the BPES gene on 3q23: mapping of a de Novo reciprocal translocation t(3;4)(q23;p15.2) breakpoint within a 45-kb cosmid and mapping of three candidate genes, RBP1, RBP2, and beta'-COP, distal to the breakpoint. <span><span class="ref-journal">Genomics. </span>1999;<span class="ref-vol">57</span>:70–8.</span> [<a href="/pubmed/10191085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10191085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.de_ru.2005.81">de Ru MH, Gille JJ, Nieuwint AW, Bijlsma JB, van der Blij JF, van Hagen JM. Interstitial deletion in 3q in a patient with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and microcephaly, mild mental retardation an growth delay: clinical report and review of the literature. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">137</span>:81–7.</span> [<a href="/pubmed/16015581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16015581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.decock.2011a.368">Decock CE, Claerhout I, Leroy BP, Kesteleyn P, Shah AD, De Baere E. Correction of the lower eyelid malpositioning in the blepharophimosis-ptosis-epicanthus inversus syndrome. <span><span class="ref-journal">Ophthal Plast Reconstr Surg. </span>2011a;<span class="ref-vol">27</span>:368–70.</span> [<a href="/pubmed/21562436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21562436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.decock.2011b.1018">Decock CE, Shah AD, Delaey C, Forsyth R, Bauters W, Kestelyn P, De Baere E, Claerhout I. Increased levator muscle function by supramaximal resection in patients with blepharophimosis-ptosis-epicanthus inversus syndrome. <span><span class="ref-journal">Arch Ophthalmol. </span>2011b;<span class="ref-vol">129</span>:1018–22.</span> [<a href="/pubmed/21825186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21825186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.dhaene.2009.e1000522">D'haene B, Attanasio C, Beysen D, Dostie J, Lemire E, Bouchard P, Field M, Jones K, Lorenz B, Menten B, Buysse K, Pattyn F, Friedli M, Ucla C, Rossier C, Wyss C, Speleman F, De Paepe A, Dekker J, Antonarakis SE, De Baere E. Disease-causing 7.4 kb cis-regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000522.</span> [<a href="/pmc/articles/PMC2689649/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2689649</span></a>] [<a href="/pubmed/19543368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19543368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.dhaene.2010.e1332">D'haene B, Nevado J, Pugeat M, Pierquin G, Lowry RB, Reardon W, Delicado A, Garc&#x000ed;a-Mi&#x000f1;aur S, Palomares M, Courtens W, Stefanova M, Wallace S, Watkins W, Shelling AN, Wieczorek D, Veitia RA, De Paepe A, Lapunzina P, De Baere E. FOXL2 copy number changes in the molecular pathogenesis of BPES: unique cohort of 17 deletions. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:E1332–47.</span> [<a href="/pubmed/20232352" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20232352</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.fukushima.1991.485">Fukushima Y, Wakui K, Nishida T, Ueoka Y. Blepharophimosis sequence and de novo balanced autosomal translocation [46,XY,t(3;4)(q23;p15.2)]: possible assignment of the trait to 3q23. <span><span class="ref-journal">Am J Med Genet. </span>1991;<span class="ref-vol">40</span>:485–7.</span> [<a href="/pubmed/1746616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1746616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.gersak.2004.2767">Gersak K, Harris SE, Smale WJ, Shelling AN. A novel 30 bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: case report. <span><span class="ref-journal">Hum Reprod. </span>2004;<span class="ref-vol">19</span>:2767–70.</span> [<a href="/pubmed/15459170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15459170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.gijsbers.2008.489">Gijsbers ACJ, D'haene B, Hilhorst-Hofstee Y, Mannens M, Albrecht B, Bartholdi D, Seidel J, Witt DR, Fong C, Maisenbacher MK, Loeys B, Sangha K, Hennekam R, Bakker E, Breuning MH, De Baere E, Ruivenkamp CAL. Identification of novel candidate loci associated with blepharophimosis phenotypes. <span><span class="ref-journal">Hum Genet. </span>2008;<span class="ref-vol">124</span>:489–98.</span> [<a href="/pubmed/18953567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18953567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.gonz_lezgonz_lez.2012.107">Gonz&#x000e1;lez-Gonz&#x000e1;lez C, Garc&#x000ed;a-Hoyos M, Hernaez Calz&#x000f3;n R, Arroyo D&#x000ed;az C, Gonz&#x000e1;lez Fanego C, Lorda S&#x000e1;nchez I, S&#x000e1;nchez-Escribano F. Microdeletion found by array-CGH in girl with blepharophimosis syndrome and apparently balanced translocation t(3;15)(q23;q25). <span><span class="ref-journal">Ophthalmic Genet. </span>2012;<span class="ref-vol">33</span>:107–10.</span> [<a href="/pubmed/22171663" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22171663</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.harris.2002.729">Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. <span><span class="ref-journal">Mol Hum Reprod. </span>2002;<span class="ref-vol">8</span>:729–33.</span> [<a href="/pubmed/12149404" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12149404</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.jewett.1993.1147">Jewett T, Rao PN, Weaver RG, Stewart W, Thomas IT, Pettenati MJ. Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) associated with interstitial deletion of band 3q22: review and gene assignment to the interface of band 3q22.3 and 3q23. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">47</span>:1147–50.</span> [<a href="/pubmed/8291545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8291545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.laissue.2009.455">Laissue P, Lakhal B, Benayoun BA, Dipietromaria A, Braham R, Elghezal H, Philibert P, Sa&#x000e2;d A, Sultan C, Fellous M, Veitia R. Functional evidence implicating FOXL2 in non syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:455–7.</span> [<a href="/pubmed/19429596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19429596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.lawson.1995.963">Lawson CT, Toomes C, Fryer A, Carette MJ, Taylor GM, Fukushima Y, Dixon MJ. Definition of the blepharophimosis, ptosis, epicanthus inversus syndrome critical region at chromosome 3q23 based on the analysis of chromosomal anomalies. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:963–7.</span> [<a href="/pubmed/7633459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7633459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.li.2009.257">Li D, Zeng W, Tao J, Li S, Liang C, Chen X, Mu W, Wang X, Qin Y, Jie Y, Wei W. Mutations of the transcription factor FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. <span><span class="ref-journal">Genet Test Mol Biomarkers. </span>2009;<span class="ref-vol">13</span>:257–68.</span> [<a href="/pubmed/19371227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19371227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.liu.2014.74">Liu H, Shao Y, Zhao Z, Zhang D. One-stage correction of blepharophimosis-ptosis-epicanthus inversus syndrome using a frontalis muscle transfer technique. <span><span class="ref-journal">J Plast Surg Hand Surg. </span>2014;<span class="ref-vol">48</span>:74–9.</span> [<a href="/pubmed/23968369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23968369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.moumn_.2008.1010">Moumn&#x000e9; L, Dipietromaria A, Batista F, Kocer A, Fellous M, Pailhoux E, Veitia RA. Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:1010–9.</span> [<a href="/pubmed/18158309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18158309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.moumn_.2005.3557">Moumn&#x000e9; L, Fellous M, Veitia RA. Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:3557–64.</span> [<a href="/pubmed/16219626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16219626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.nallathambi.2007.107">Nallathambi J, Moumn&#x000e9; L, De Baere E, Beysen D, Usha K, Sundaresan P, Veitia R. A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. <span><span class="ref-journal">Hum Genet. </span>2007;<span class="ref-vol">121</span>:107–12.</span> [<a href="/pubmed/17089161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17089161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.nelson.2009.606">Nelson LM. Clinical practice. Primary ovarian insufficiency. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:606–14.</span> [<a href="/pmc/articles/PMC2762081/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2762081</span></a>] [<a href="/pubmed/19196677" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19196677</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.oley.1995">Oley C, Baraitser M. <em>Textbook of Congenital Malformation Syndromes</em><em>.</em> 1995.</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.or.2006.49">Or SF, Tong MF, Lo FM, Lam TS. Three novel FOXL2 gene mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. <span><span class="ref-journal">Chin Med J (Engl). </span>2006;<span class="ref-vol">119</span>:49–52.</span> [<a href="/pubmed/16454982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16454982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.pisarska.2004.3424">Pisarska MD, Bae J, Klein C, Hsueh AJ. Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. <span><span class="ref-journal">Endocrinology. </span>2004;<span class="ref-vol">145</span>:3424–33.</span> [<a href="/pubmed/15059956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15059956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.praphanphoj.2000.67">Praphanphoj V, Goodman BK, Thomas GH, Niel KM, Toomes C, Dixon MJ, Geraghty MT. Molecular cytogenetic evaluation in a patient with a translocation (3;21) associated with blepharophimosis, ptosis, epicanthus inversus syndrome (BPES). <span><span class="ref-journal">Genomics. </span>2000;<span class="ref-vol">65</span>:67–9.</span> [<a href="/pubmed/10777667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10777667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.prueitt.2001.132">Prueitt RL, Zinn AR. A fork in the road to fertility. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">27</span>:132–4.</span> [<a href="/pubmed/11175772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11175772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.qian.2004.19">Qian X, Shu A, Qin W, Xing Q, Gao J, Yang J, Feng G, He L. A novel insertion mutation in the FOXL2 gene is detected in a big Chinese family with blepharophimosis-ptosis-epicanthus inversus. <span><span class="ref-journal">Mutat Res. </span>2004;<span class="ref-vol">554</span>:19–22.</span> [<a href="/pubmed/15450400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15450400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.sa.2012.2402">Sa HS, Lee JH, Woo KI, Kim YD. A new method of medial epicanthoplasty for patients with blepharophimosis-ptosis-epicanthus inversus syndrome. <span><span class="ref-journal">Ophthalmology. </span>2012;<span class="ref-vol">119</span>:2402–7.</span> [<a href="/pubmed/22835816" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22835816</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.schladebartusiak.2012.2322">Schlade-Bartusiak K, Brown L, Lomax B, Bruy&#x000e8;re H, Gillan T, Hamilton S, McGillivray B, Eydoux P. BPES with atypical premature ovarian insufficiency, and evidence of mitotic recombination, in a woman with trisomy X and a translocation t(3;11)(q22.3;q14.1). <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:2322–7.</span> [<a href="/pubmed/22887799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22887799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.sebasti_.2011.820">Sebasti&#x000e1; R, Herzog Neto G, Fallico E, Lessa S, Solari HP, Ventura MP. A one-stage correction of the blepharophimosis syndrome using a standard combination of surgical techniques. <span><span class="ref-journal">Aesthetic Plast Surg. </span>2011;<span class="ref-vol">35</span>:820–7.</span> [<a href="/pubmed/21455822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21455822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.udar.2003.222">Udar N, Yellore V, Chalukya M, Yelchits S, Silva-Garcia R, Small K. Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">22</span>:222–8.</span> [<a href="/pubmed/12938087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12938087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.verdin.2013.e1003358">Verdin H, D'haene B, Beysen D, Novikova Y, Menten B, Sante T, Lapunzina P, Nevado J, Carvalho C, Lupski JR, De Baere E. Microhomology-mediated replication-based mechanisms underly non-recurrent pathogenic microdeletions of the FOXL2 gene or its regulatory domain. <span><span class="ref-journal">PLoS Genet. </span>2013;<span class="ref-vol">9</span>:e1003358.</span> [<a href="/pmc/articles/PMC3597517/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3597517</span></a>] [<a href="/pubmed/23516377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23516377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.wu.2008.380">Wu SY, Ma L, Tsai YJ, Kuo JZ. One-stage correction for blepharophimosis syndrome. <span><span class="ref-journal">Eye (Lond). </span>2008;<span class="ref-vol">22</span>:380–8.</span> [<a href="/pubmed/17115018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17115018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="bpes.REF.zlotogora.1983.1020">Zlotogora J, Sagi M, Cohen T. The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. <span><span class="ref-journal">Am J Hum Genet. </span>1983;<span class="ref-vol">35</span>:1020–7.</span> [<a href="/pmc/articles/PMC1685801/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1685801</span></a>] [<a href="/pubmed/6613996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6613996</span></a>]</div></li></ul></div></div><div id="bpes.Chapter_Notes"><h2 id="_bpes_Chapter_Notes_">Chapter Notes</h2><div id="bpes.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>5 February 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 November 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 February 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available</div></li><li class="half_rhythm"><div>12 July 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 July 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>1 March 2004 (edb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1441</span><span class="label">PMID: <a href="/pubmed/20301614" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301614</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/bhd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/bloom/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1441&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1441/?report=reader">PubReader</a></li><li><a href="/books/NBK1441/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1441" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1441" style="display:none" title="Cite this Page"><div class="bk_tt">Verdin H, De Baere E. Blepharophimosis, Ptosis, and Epicanthus Inversus. 2004 Jul 8 [Updated 2015 Feb 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1441/pdf/Bookshelf_NBK1441.pdf">PDF version of this page</a> (477K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#bpes.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#bpes.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#bpes.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#bpes.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#bpes.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#bpes.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#bpes.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#bpes.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#bpes.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#bpes.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#bpes.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=668[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FOXL2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1470484" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470484" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470484" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1470484" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21934608" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Blepharophimosis-ptosis-epicanthus inversus syndrome plus: deletion 3q22.3q23 in a patient with characteristic facial features and with genital anomalies, spastic diplegia, and speech delay.</a><span class="source">[Clin Dysmorphol. 2012]</span><div class="brieflinkpop offscreen_noflow">Blepharophimosis-ptosis-epicanthus inversus syndrome plus: deletion 3q22.3q23 in a patient with characteristic facial features and with genital anomalies, spastic diplegia, and speech delay.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Zahanova S, Meaney B, Łabieniec B, Verdin H, De Baere E, Nowaczyk MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Dysmorphol. 2012 Jan; 21(1):48-52. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28849110" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis‑-ptosis-epicanthus inversus syndrome.</a><span class="source">[Mol Med Rep. 2017]</span><div class="brieflinkpop offscreen_noflow">Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis‑-ptosis-epicanthus inversus syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yang L, Li T, Xing Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Med Rep. 2017 Oct; 16(4):5529-5532. Epub 2017 Aug 10.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25192944" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).</a><span class="source">[Eur J Med Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gulati R, Verdin H, Halanaik D, Bhat BV, De Baere E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Med Genet. 2014 Oct; 57(10):576-8. Epub 2014 Sep 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22241538" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Blepharophimosis ptosis epicanthus inversus syndrome (BPES) (corrected)].</a><span class="source">[Klin Monbl Augenheilkd. 2012]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Blepharophimosis ptosis epicanthus inversus syndrome (BPES) (corrected)].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tyers A, Meyer-Rüsenberg HW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Klin Monbl Augenheilkd. 2012 Jan; 229(1):28-30. Epub 2012 Jan 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16208278" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.</a><span class="source">[Pediatr Endocrinol Rev. 2005]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">De Baere E, Copelli S, Caburet S, Laissue P, Beysen D, Christin-Maitre S, Bouchard P, Veitia R, Fellous M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Endocrinol Rev. 2005 Jun; 2(4):653-60. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301614" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301614" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041742dd21425a252a7770">Blepharophimosis, Ptosis, and Epicanthus Inversus - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Blepharophimosis, Ptosis, and Epicanthus Inversus - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:13:22-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A32F8E04083F10000000006660255&amp;ncbi_session=CE8A32F8E0417411_1638SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1441%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1441&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1441/&amp;ncbi_pagename=Blepharophimosis, Ptosis, and Epicanthus Inversus - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A32F8E0417411_1638SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>